death from semaglutide FDA approves new Wegovy (semaglutide) indication to reduce cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity or overweight FDA Expands Semaglutide Use Electrolyte+ Flavour:Pineapple Punch breakfast

death from semaglutide FDA approves new Wegovy (semaglutide) indication to reduce cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity or overweight FDA Expands Semaglutide Use Electrolyte+ Flavour:Pineapple Punch breakfast

FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD | AJMC

But the trial did not measure lean mass versus fat mass in detail

breakfast

Electrolyte+ Flavour:Pineapple Punch

For those in perimenopause, undergoing GLP-1 therapy can help them manage health concerns at a younger age before they develop into more serious problems during postmenopause